期刊文献+

2型糖尿病合并非酒精性脂肪肝病患者血脂代谢与冠心病的关系 被引量:3

Relationship between Lipid Metabolism and Coronary Heart Disease in Patients with Type Ⅱ Diabetic Combined with Nonalcoholic Fatty Liver Disease
下载PDF
导出
摘要 目的:探讨2型糖尿病合并非酒精性脂肪肝病(NAFLD)患者的血脂谱特点及其与冠心病的关系。方法:对我院收治的2型糖尿病患者492例根据病史及肝脏B超检查结果分为NAFLD组和非NAFLD组,观察其血脂谱特点及其与冠心病患病率的关系。结果:341例(69.3%)住院2型糖尿病患者伴NAFLD,其中259例(76.0%)肝功能正常且无明显症状;NAFLD组有较高的丙氨酸转氨酶(ALT)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)水平,与非NAFLD组比较,差异有显著性(P<0.01);NAFLD组冠心病患病率明显高于非NAFLD组,差异有显著性(P<0.01),其中ALT升高组冠心病的患病率较ALT正常者升高,差异亦有显著性(P<0.05)。结论:2型糖尿病患者NAFLD发生率高,且大多数无症状,其发生可能与体脂分布异常、血脂代谢紊乱等因素相关,NAFLD增加了2型糖尿病患者冠心病的风险,ALT可作为其预测指标。 Objective:To assess the relationship between lipid metabolism and coronary heart disease(CHD) m patienrs with Type Ⅱ diabetic combined with nonalcoholic fatty liver disease. Methods :The 492 padentsrelinieal data were collected since 2002. and they were divided into two groups (NAFLD-Group and non-NAFLD group) by liver ultrasoriography. Results :Among them. 341 cases (69.3 % ) were complicated with NAFLD. and 259 cases (76 % ) had normal liver function and no symptom ;NAFLD group had higher alanine aminotransferase (ALT).triglyeerides (TG) and low density lipoprotein lipoprotein cholesterol (LDL-C) levels than those without NAFLD(P〈0.01 ) ; Moreover. the prevalence of CHD was also higher in NAFLD group, especially in those with elevated plasma ALT (P〈0. )5). Conclusion: NAFLD is acommon condition complicated with Type 2 diabetes, the occurrences may be related with abdominal obesity, dyslipi demia metabolism: NAFLD increases the risk of CHD and plasma ALT levels may be acted as a marker.
出处 《中国误诊学杂志》 CAS 2008年第25期6049-6051,共3页 Chinese Journal of Misdiagnostics
关键词 糖尿病 Ⅱ型/并发症/血液 脂肪肝/并发症/血液 丙氨酸转氨酶/血液 甘油三酯类/血液 脂蛋白类 LDL胆固醇/血液 冠状动脉疾病/病因学 Diabetes Mellbus, Type 2/complications /blood Fatty Liver/complications /blood Alanine Transaminase/blood Triglycerides/blood Lipoproreins, LDL Cholesterol/blood Coronary Disease/etiology
  • 相关文献

参考文献7

  • 1Neuschwander-Tetri BA. Nonalcoholic Steatohepatitis and the metabolic syndrome[J].Am J Med Sci, 2005,330 (6):326-335.
  • 2Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1511
  • 3Riikka L, Ronald B;Patricia I,et al. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes[J]. Am J Physiol Endocrinol Metab, 2006,291:282-290.
  • 4Targher G,Bertolini L,Padovani R,et al. InIncreased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease[J].Diabet Med, 2006,23 : 403-409.
  • 5Fan JG. Impact of non-alcoholic fatty liver disease on accelerated metabolic complications[J]. J Dig Dis, 2008,9 (2) : 63-67.
  • 6Schindhelm RK, Diamant M, Dekket JM, et al. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetesmellitus and cardiovascular disease[J].Diabetes Metab Res Rev, 2006,22 (6) : 437-443.
  • 7Schindhelm RK, Diamant M, Bakker SJ, et al. Liver alanine aminotransferase,insulin resistance and endothelial dysfunction in normotriglyceridaemic subiects with type 2 diabetes mellitus[J]. Eur J Clin Invest, 2005,35 (6) : 369-374.

二级参考文献18

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649.
  • 3Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219.
  • 4Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231.
  • 5Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.
  • 6Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490.
  • 7Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44.
  • 8Agrawal S,Bonkovsky HL.Management of nonalcoholic steatohepatitis:an analytic review.J Clin Gastroenterol,2002,35:253-261.
  • 9Comar KM,Sterling RK.Drug therapy for non-alcoholic fatty liver disease.Aliment Pharmacal Ther,2006,23:207-215.
  • 10Lok AS,McMahon B J; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.

共引文献1510

同被引文献32

  • 1李霞,周智广,亓海英,陈小燕,黄干.用空腹C肽代替胰岛素改良Homa公式评价胰岛素抵抗和胰岛β细胞功能[J].中南大学学报(医学版),2004,29(4):419-423. 被引量:207
  • 2Andersen T,Gluud C.Liver morphology in morbid obesity:a literature study[J].Int J Obes,1984,8:97-106.
  • 3Bellentani S,Saccocio G,Masutti F,et al.Prevalence of and risk factors for hepatic steatosis in northern Italy[J].Ann Intern Med,2000,132:112-117.
  • 4Guenther Boden.Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver[J].Current Science Inc,2006,6:177-181.
  • 5Fan JG,Saibara T,Chitturi S,et al.What are the risk factors andsettings for non-alcoholic fatty liver disease in Asia-Pacific?[J].J Gastroenterol Hepatol,2007,22:794-800.
  • 6Fan JG.Impact of non-alcoholic fatty liver disease on accelerated metabolic complications[J].J Dig Dis,2008,9(2):63-67.
  • 7朱红霞 朱筠 张明琛 等.维吾尔族和汉族2型糖尿病合并非酒精性脂肪肝患者的代谢特征及相关危险因素探讨.中国全科医学,2009,12(7):1164-1164.
  • 8Shibata M,Kihara Y,Taguchi M,et al.Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men[J].Diabetes Care,2007,30:2940-2944.
  • 9Schindhelm RK,Diamant M,Dekker JM,et al.Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease[J].Diabetes Metab Res Rev,2006,22(6):437-443.
  • 10Hanley AJ,Williams K,Festa A,et al.Liver markers and development of the metabolic syndrome:the insulin resistance atherosclerosis study[J].Diabetes,2005,54:3140-3147.

引证文献3

二级引证文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部